Demis Hassabis, CEO of Google DeepMind and a Nobel prizewinner for his role in developing the AlphaFold AI algorithm for predicting protein structures, made an incredible statement on the 60 Minutes show in April. He claimed that with the assistance of AI like AlphaFold, the eradication of all diseases is on the horizon, possibly within the next decade. This bold assertion has sparked skepticism among those actively engaged in drug development and disease treatment.
While some view Hassabis’s remarks as typical of tech leaders exaggerating to attract investment, it raises questions about the responsibility of experts in their respective fields. Hassabis and other AI pioneers like Geoffrey Hinton have made statements that, although rooted in their work, may lack a comprehensive understanding of the broader implications of their technologies.
For instance, Daniel Kokotajlo, a former OpenAI researcher, has raised concerns about AI’s potential to deceive, showcasing a disconnect between the perception of AI capabilities and their actual functioning. Similarly, Hinton’s suggestion in 2016 that radiologists should cease training due to AI advancements highlights the need for a balanced approach to integrating technology into various industries.
These instances underscore the importance of critically evaluating expert claims and not succumbing to unwarranted hype. While advancements in AI hold promise for medical and scientific breakthroughs, a cautious and informed approach is essential to avoid complacency and ensure progress is made responsibly.
Philip Ball is a science writer based in London. His latest book is How Life Works
Topics:
- artificial intelligence/
- technology
